Related Experiment Videos
Immune-Mediated Diseases II Congress: summary
Michael R Shurin1, Yury S Smolkin
1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. shurinmr@upmc.edu
Journal of Immunotoxicology
|June 24, 2008
Summary
Clinical immunology applies basic immunology to diagnose and treat diseases involving immune pathways. This field addresses infections, cancer, AIDS, transplantation, immunodeficiencies, and allergies, highlighting immune-mediated diseases as a significant health concern.
Area of Science:
- Immunology
- Clinical Immunology
- Immunotoxicology
Background:
- The immune system is crucial for fighting infections and implicated in cancer, AIDS, and organ transplantation.
- Immune system imbalance causes immunodeficiencies, hypersensitivities (asthma, allergies), and autoimmune disorders (multiple sclerosis, rheumatoid arthritis, diabetes).
- Immune-mediated diseases (autoimmune and allergic) are significant global health issues, affecting up to 8% of the US population and leading to chronic illness and disability.
Framework:
- Clinical immunology integrates basic immunological principles for patient diagnosis, treatment, and prevention.
- Focuses on diseases with significant etiological and pathogenetic roles for immunological pathways.
- Emphasizes a multidisciplinary approach involving clinicians, scientists, pharmacists, and biotech professionals.
Implementation:
- The Second International Immune-Mediated Diseases (IMD) Congress aimed to advance immunological sciences and clinical practice.
- Achieved through sessions, training courses, and fostering scientific discussion and idea exchange.
- Facilitated consideration of novel clinical diagnostic and therapeutic strategies for immune-mediated diseases.
Implications:
- Advances in basic immunology have led to the emergence of clinical immunology as a distinct discipline.
- Immune-mediated diseases pose substantial medical, social, and economic challenges.
- The congress provided a platform for sharing research and clinical insights, contributing to the Journal of Immunotoxicology.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...